Search results

Filter

Filetype

Your search for "*" yielded 128642 hits

Does Alzheimer’s disease start inside neurons? – PhD interview with Tomas Roos

The aggregation of the protein Amyloid-beta (Abeta) into plaques outside the nerve cells has been recognized in patients with Alzheimer’s disease since 1905. But eliminating the plaques has not helped patients so far. Still, Tomas Roos thinks that Abeta matters, but we may need to focus on the aggregates elsewhere. On February 17, he defends his thesis about prion-like proteins in neurodegeneratio

https://www.multipark.lu.se/article/does-alzheimers-disease-start-inside-neurons-phd-interview-tomas-roos - 2025-12-19

First patient receives milestone stem cell-based transplant for Parkinson’s Disease

On 13th of February, a transplant of stem cell-derived nerve cells was administered to a person with Parkinson’s at Skåne University Hospital, Sweden. The product has been developed by Lund University and it is now being tested in patients for the first time. The transplantation product is generated from embryonic stem cells and functions to replace the dopamine nerve cells which are lost in the p

https://www.multipark.lu.se/article/first-patient-receives-milestone-stem-cell-based-transplant-parkinsons-disease - 2025-12-19

Electrodes grown in the brain

The boundaries between biology and technology are becoming blurred. Researchers at Linköping, Lund, and Gothenburg universities in Sweden have successfully grown electrodes in living tissue using the body’s molecules as triggers. The result, published in the journal Science, paves the way for the formation of fully integrated electronic circuits in living organisms. This news was initially publish

https://www.multipark.lu.se/article/electrodes-grown-brain - 2025-12-19

Genes and environment in PD – PhD interview with Kajsa Brolin

Kajsa Brolin explores how our genes and environment affect the risk of developing Parkinson’s disease. March 27, she defends her Ph.D. project partly based on MultiPark’s biobank sample collection. Here, she tells about the newly discovered genetic risk factor that might be specific to people in the southern part of Sweden. And is coffee really protective? Tell us about your research! “My research

https://www.multipark.lu.se/article/genes-and-environment-pd-phd-interview-kajsa-brolin - 2025-12-19

STEM-PD : A bench-to-bedside story by MultiPark researchers

After a decade of protocol development and preparations, MultiPark researchers have finally launched the clinical trial. Recently, dopamine-producing cells generated from embryonic stem cells were transplanted into the first Parkinson's patient at Skåne University Hospital. During the autumn 2022, the Swedish MPA (Läkemedelsverket) approved the clinical STEM-PD study. Several of MultiParks PIs hav

https://www.multipark.lu.se/article/stem-pd-bench-bedside-story-multipark-researchers-0 - 2025-12-19

Meet Our Scientists! – New podcast by young MultiPark researchers

Looking for the next step in your career? In need of some scientific inspiration? Or are you just curious about what MultiPark´s senior researchers are doing and their professional journey? Listen to MultiPark’s new podcast series “Meet our scientists”! In a newly launched podcast, young MultiPark researchers interview our research group leaders about their academic journey and main scientific foc

https://www.multipark.lu.se/article/meet-our-scientists-new-podcast-young-multipark-researchers - 2025-12-19

WORLD PARKINSON's DAY: Transplantations for Parkinson's disease – A time travel

In the early 1950s, no one knew what caused Parkinson's disease. Then, Arvid Carlsson's discovery of dopamine opened the door to world-leading transplantations for Parkinson's patients. Thanks to the pioneering basic research at MultiPark, stemcell-derived neural cells can now be tested in a clinical trial for the first time. In Parkinson's disease, the nerve cells in an area of the brain that con

https://www.multipark.lu.se/article/world-parkinsons-day-transplantations-parkinsons-disease-time-travel - 2025-12-19

Genetics of Neurodegenerative Diseases – A special interest group

Genetics are one of the keys to understanding neurodegenerative disease. That is why MultiPark researchers with expertise in genetics gather across research groups. Genetics of neurodegenerative diseases is a new special interest group (SIG) addressing scientific and technological needs to unravel the genetics behind diseases such as Parkinson’s and Alzheimer’s. Andreas Puschmann tells about how h

https://www.multipark.lu.se/article/genetics-neurodegenerative-diseases-special-interest-group - 2025-12-19

Double success for MultiPark research groups in prestigious EU grant round

Three researchers at Lund University, all with a long list of significant research credentials, have been awarded the ERC Advanced Grant worth EUR 2.5 million each to further develop and advance their research projects. Two of them are MultiPark research leaders. They do research on chaperone proteins’ function in neurodegenerative diseases and blood tests for rapid screening of drugs in the treat

https://www.multipark.lu.se/article/double-success-multipark-research-groups-prestigious-eu-grant-round - 2025-12-19

Superstars coming to Lund for pharmaceutical symposium sponsored by MultiPark

Several Nobel laureates, renowned scientists, and successful biotech entrepreneurs are coming to Lund in May to participate in the Lund Spring Symposium, an international pharmaceutical symposium sponsored by MultiPark. Sarah Tabrizi, a high profile Huntington researcher, and some of MultiPark's own researchers will speak. Medications are the physician's primary tool when treating their patients,

https://www.multipark.lu.se/article/superstars-coming-lund-pharmaceutical-symposium-sponsored-multipark - 2025-12-19

Acquired brain injuries – A special interest group

Recent studies indicate that acquired brain injuries, such as traumatic brain injury, trigger potentially harmful responses that may lead to neurodegenerative pathology. “Acquired brain injuries and their links to neurodegeneration diseases” is a new special interest group (SIG) collaborating across research groups to elucidate molecular processes that may mediate the relation between acquired bra

https://www.multipark.lu.se/article/acquired-brain-injuries-special-interest-group - 2025-12-19

Connecting the Seas of Norden

See the recent article with Daniel Conley in Nature Climate Change on Connecting the Seas of Norden.The Nordic Seas are highly sensitive to environmental change and have been extensively monitored and studied across a broad range of marine disciplines. For these reasons, the Nordic seas may serve as a pilot area for integrated policy development in response to ongoing climate change.Read more..

https://www.geology.lu.se/article/connecting-seas-norden - 2025-12-19

Svante Björck has been elected as a Fellow of The American Association for the Advancement of Sciences (AAAS).

Svante Björck has been elected as a Fellow of The American Association for the Advancement of Sciences (AAAS).“For distinguished contributions reconstructing Quaternary environments in the northern and southern hemispheres, and for leadership in the international community of Quaternary geoscientists.”AAAS: https://www.aaas.org/List of elected Fellows 2017: https://www.aaas.org/page/2017-fellows

https://www.geology.lu.se/article/svante-bjorck-has-been-elected-fellow-american-association-advancement-sciences-aaas - 2025-12-19

Oxygen in the World’s Oceans is Declining, Scientists Reveal Dangers and Solutions

In the past 50 years, the amount of water in the open ocean without oxygen has gone up more than four-fold. In coastal water bodies, including estuaries and seas, low-oxygen sites have increased more than 10-fold since 1950. Protecting sensitive species, controlling eutrophication and climate change and improving monitoring are some solutions to the problem, according to researchers from, among ot

https://www.geology.lu.se/article/oxygen-worlds-oceans-declining-scientists-reveal-dangers-and-solutions - 2025-12-19